Meanwhile, C-MYC can undergo targeted binding with NCOA4 and inhibit ferritin autophagy and ferroptosis in ovarian cancer cells through the NCOA4 axis, which is consistent with the results of previous studies. This evidence concerns the gene MYC and ovarian cancer.